Atlas Trials

Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations

Clinical trial NCT02928211 · UNKNOWN

Trial details

NCT number
NCT02928211
Sponsor
Cognoptix, Inc.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Mild Cognitive ImpairmentAlzheimer's Disease
Start date
2016-07-01
Primary completion
2018-12-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.